FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036825 [Registered on: 24/09/2021] Trial Registered Prospectively
Last Modified On: 02/08/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   efficacy between Gunjaphaladi Lepa and Avalgujbeejadi Lepa in Vitiligo 
Scientific Title of Study   A Comparative Clinical Study of Gunjaphaladi Lepa and Avalgujbeejadi Lepa in the management of Kilaasa (Vitiligo) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Praveen Kumar 
Designation  M.D (Ay.) Scholar 
Affiliation  Government Ayurvedic College, Patna 
Address  Department of Agada Tantra evam Vidhi Vaidyaka Government Ayurvedic College Kadamkuan Patna

Patna
BIHAR
800003
India 
Phone  9709834134  
Fax    
Email  ayushpk5@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jai Kumar Singh 
Designation  Professor & HOD 
Affiliation  Government Ayurvedic College, Patna 
Address  Department of Agada Tantra evam Vidhi Vaidyaka Government Ayurvedic College Kadamkuan Patna

Patna
BIHAR
800003
India 
Phone  9199373517  
Fax    
Email  jai.kumar1966@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jai Kumar Singh 
Designation  Professor & HOD 
Affiliation  Government Ayurvedic College, Patna 
Address  Department of Agada Tantra evam Vidhi Vaidyaka Government Ayurvedic College Kadamkuan Patna


BIHAR
800003
India 
Phone  9199373517  
Fax    
Email  jai.kumar1966@rediffmail.com  
 
Source of Monetary or Material Support  
Research unit-OPD No-10 Government Ayurvedic College & Hospital, Kadamkuan, Patna Pin- 800003 
 
Primary Sponsor  
Name  Government Ayuvedic College Patna 
Address  Government Ayurvedic College & Hospital, Kadamkuan Patna Pin-800003 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Praveen Kumar  Government Ayurvedic College & Hospital, Patna  Room No-10 Research unit Government Ayurvedic College and Hospital Kadamkuan Patna- 800003
Patna
BIHAR 
9709834134

ayushpk5@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics Committee, Government Ayurvedic College, Patna- 800003  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L80||Vitiligo. Ayurveda Condition: Kilaasa ,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Gunjaphaladi Lepa, Reference: Bhaishajya Ratnawali Kustha Roga/49, Route: Topical, Dosage Form: Churna/ Powder, Dose: 10(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information:
2Intervention ArmDrugClassical(1) Medicine Name: Avalgujbeejadi Lepa, Reference: Chakradutta Kustha Chikitsa/69, Route: Topical, Dosage Form: Churna/ Powder, Dose: 10(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 3 Months, anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  -as per classical sign and symptoms described in ayurvedic texts and modern literature.
- Prediagnosed patient of Kilaasa(vitiligo) 
 
ExclusionCriteria 
Details  -Patients below 12 yrs. and above 60 yrs.
-Chronicity of kilaasa more than 5 yrs.
-Patients associated with diabetes, AIDS, Hep-B, leukemia
-Pregnant women/lactating women
-white anesthetic spots which are character of leprosy. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The assessment will be based on the color, size,VETF, VIDA score, margins of the lesion and % of area involvement of the white patches.  Patients will be followed up after 15 days up to 3 months of trial. 
 
Secondary Outcome  
Outcome  TimePoints 
Improvemeent in the quality of kilaasa(vitiligo)  Evaluation will be done after 90 days. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="56" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/10/2021 
Date of Study Completion (India) 28/05/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
In this study, 60 clinically diagnosed and confirmed patients of kilaasa (vitiligo) will be divided into 2 groups of 30 patients each.
Group I will be given Gunjaphaldi lepa and Group II will be given Avalgujbeejadi lepa.
The data will be collected and assessed by different scales of measurement. 6 evaluation will be done by follow up after every 15 days
The patients will be evaluated on the basis of subjective and objective parameter to assess the efficacy of the intervention.

 
Close